The bottles fail to meet the federal child-resistant closure requirement
Clik here to view.
of ConsumerAffairsClik here to view.
GlaxoSmithKline (GSK) of Moon Township, Pa., is recalling about 10,600 bottles of Panadol Advance 100-count caplets.
The packaging is not child-resistant. These products contain acetaminophen, which is required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.
No incidents or injuries have been reported.
This recall involves bottles of 100-count Panadol Advance pain relievers. The medicine was sold in white containers with a blue label, inside a blue box. “Panadol” and “Advance” are printed on the label. Lot numbers and dates codes are located on the left side panel of the box and on the left side of the label on the bottle, near the bar code.
Lot numbers and date codes included in the recall are:
- Lot number: 14241, expiration date: 02/2015
- Lot number: 14002, expiration date: 10/2014
- Lot number: 13881, expiration date: 09/2014
- Lot number: 13801, expiration date: 09/2014
The caplets, manufactured in the U.S., were sold exclusively at drug, grocery and mass merchandise stores in Puerto Rico from November 2012, through February 2014, for about $10.
Consumers should immediately place the product out of a child’s sight and reach, and contact GSK for a refund.
Consumers may contact GlaxoSmithKline toll-free at (888) 912-8455 from 9 a.m. to 5 p.m. ET Monday through Friday.
